FDA Approved: TASIGNA — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved Tasigna (nilotinib) through the original application (NDA022068) for Philadelphia chromosome-positive chronic myeloid leukemia. This introduced a s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Tasigna (nilotinib)

Snippet

ORIG AP for TASIGNA (NILOTINIB)